Barbara Kreppel
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 08, 2026
External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 18, 2026
Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer.
Journal: Nuklearmedizin. Nuclear medicine
Published: December 04, 2025
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors.
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors.
Journal: Nuklearmedizin. Nuclear medicine
Published: December 01, 2025
Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 19, 2025
Psycho-Oncological Screening Identifies High-Risk Subgroups Among Neuroendocrine Tumor Patients Undergoing PRRT with [177Lu]Lu-DOTATATE: Implications for Survival.
Journal: Nuklearmedizin. Nuclear medicine
Published: June 30, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN).
Journal: European journal of nuclear medicine and molecular imaging
Published: May 14, 2025
Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate.
Journal: Frontiers in oncology
Published: May 01, 2022
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours.
Journal: Nuklearmedizin. Nuclear medicine
Published: July 13, 2021
[In Reply: Invisible Hand - Re: [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging].
Journal: Nuklearmedizin. Nuclear medicine
Published: December 18, 2020
Sialoscintigraphy - Shopworn or Bestselling? A Traditional Procedure with New Prominent Role in Theranostics and Immuno-Oncology.
Journal: Nuklearmedizin. Nuclear medicine
Published: May 19, 2020
Last Updated: 09/26/2026